{"id":69029,"date":"2026-03-13T12:12:34","date_gmt":"2026-03-13T12:12:34","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69029"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"ss-31-elamipretide","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-br\/product\/ss-31-elamipretide\/","title":{"rendered":"SS-31 (Elamipretide)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 SS-31 (Elamipretide)?<\/h3>\n<p style=\"margin: 0;\"><strong>SS-31<\/strong> (tamb\u00e9m chamado <strong>Elamipretide<\/strong> ou <strong>Bendavia<\/strong>) \u00e9 um tetrapept\u00eddeo sint\u00e9tico que se liga seletivamente <strong>cardiolipina<\/strong> on the inner mitochondrial membrane, stabilizing mitochondrial function under stress. Developed by the Szeto-Schiller lab and now in late-stage clinical development by Stealth BioTherapeutics with FDA orphan-drug designation for rare mitochondrial disease. Supplied in 5\u00a0mg to 50\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que voc\u00ea obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-br\/reviews\/\">\ud83d\udce6 Cada pedido \u00e9 coberto pela nossa<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Todo pedido \u00e9 coberto pelo nosso <a href=\"https:\/\/medsbase.com\/pt-br\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Reenvio Garantido<\/strong><\/a> \u2014 se sua encomenda n\u00e3o chegar em 20 dias \u00fateis, n\u00f3s a reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">736992-21-5<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>32<\/sub>H<sub>49<\/sub>N<sub>9<\/sub>O<sub>5<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">639.80 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Arg-2\u2032,6\u2032-Dmt-Lys-Phe-NH<sub>2<\/sub> (Bendavia, MTP-131)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">P\u00f3 liofilizado (ou conforme fornecido)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA sob solicita\u00e7\u00e3o)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (geladeira) para estoque de trabalho; \u221220 \u00b0C para armazenamento de longo prazo de frascos fechados. Reconstitu\u00eddo: 2\u20138 \u00b0C, usar em at\u00e9 ~30 dias. Proteger da luz. N\u00e3o congelar e descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada) ou \u00e1gua est\u00e9ril para per\u00edodos de uso mais curtos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O Que \u00c9 SS-31 (Elamipretide)?<\/h2>\n<p><strong>SS-31<\/strong> \u00e9 um tetrapept\u00eddeo sint\u00e9tico perme\u00e1vel \u00e0s c\u00e9lulas (D-Arg-2\u20196\u2032-dimetil-L-Tyr-L-Lys-L-Phe, tamb\u00e9m abreviado <strong>Szeto-Schiller 31<\/strong>) desenvolvido por Hazel Szeto e Peter Schiller na Weill Medical College da Cornell a partir dos anos 1990. Tamb\u00e9m \u00e9 conhecido pelos nomes de desenvolvimento farmac\u00eautico <strong>Elamipretide<\/strong> e <strong>Bendavia<\/strong>, e est\u00e1 sendo desenvolvido clinicamente pela <strong>Stealth BioTherapeutics<\/strong>. Unlike most peptides that bind cell-surface receptors, SS-31 is a <strong>agente direcionado \u00e0s mitoc\u00f4ndrias<\/strong> que atravessa membranas celulares e de organelas para alcan\u00e7ar a membrana mitocondrial interna, onde se liga <strong>cardiolipina<\/strong> \u2014 a phospholipid unique to that location. This selective lipid binding underpins its mechanism of action and distinguishes SS-31 from virtually every other peptide. Molecular weight approximately 640\u00a0Da. SS-31 has <strong>designa\u00e7\u00e3o de medicamento \u00f3rf\u00e3o pela FDA<\/strong> for primary mitochondrial myopathy and has been the subject of multiple human clinical trials \u2014 placing it further along the clinical development pipeline than most peptides. It is supplied here as a high-purity lyophilized powder <strong>for clinical studies use only<\/strong> (Stealth&#8217;s clinical product is a separate regulated therapeutic). For deeper mechanism, Szeto lab studies history, and clinical-trial context, see our <a href=\"https:\/\/medsbase.com\/pt-br\/ss-31-elamipretide-mitochondrial-guide\/\">SS-31 guide<\/a>. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Estabiliza\u00e7\u00e3o Mitocondrial Direcionada \u00e0 Cardiolipina<\/h2>\n<p>SS-31&#8217;s mechanism is unique among peptides because its target is a phospholipid, not a receptor protein. Three interconnected effects define its pharmacology:<\/p>\n<ul>\n<li><strong>Liga\u00e7\u00e3o \u00e0 cardiolipina<\/strong> \u2014 O SS-31 se liga seletivamente \u00e0 cardiolipina na membrana mitocondrial interna. A cardiolipina \u00e9 um lip\u00eddio caracter\u00edstico encontrado quase exclusivamente nessa localiza\u00e7\u00e3o e \u00e9 essencial para a arquitetura das cristas (a superf\u00edcie dobrada da membrana interna onde os complexos da cadeia de transporte de el\u00e9trons se agrupam). A liga\u00e7\u00e3o do SS-31 <strong>estabiliza a morfologia das cristas<\/strong> durante estresse que, de outra forma, causaria ruptura das cristas e disfun\u00e7\u00e3o mitocondrial.<\/li>\n<li><strong>Redu\u00e7\u00e3o de ROS e preserva\u00e7\u00e3o da CTE<\/strong> \u2014 by preserving cristae architecture, SS-31 maintains the proper organization of electron-transport-chain complexes, preserving ATP synthesis and reducing electron &#8220;leakage&#8221; that generates reactive oxygen species. In ischemia-reperfusion study models, this translates to reduced oxidative damage and preserved mitochondrial function.<\/li>\n<li><strong>Preven\u00e7\u00e3o da libera\u00e7\u00e3o de citocromo c<\/strong> \u2014 mitochondrial apoptosis begins with cytochrome c release from the inner membrane space into the cytoplasm. By preserving cristae structure, SS-31 preserves cytochrome c localization and blocks a critical apoptotic trigger. This is central to its cardiac ischemia-reperfusion signal.<\/li>\n<\/ul>\n<p>The practical studies implication: SS-31 is the reference mitochondria-targeted peptide. Where other peptides act at cell-surface receptors, SS-31 acts inside the organelle, preserving mitochondrial function in study models of metabolic stress, ischemia, and aging. <\/p>\n<h2>Published Evidence<\/h2>\n<p>SS-31 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Primary mitochondrial disease studies<\/strong> \u2014 rare mitochondrial myopathy studies including Barth syndrome; SS-31 has FDA orphan-drug designation for this indication<\/li>\n<li><strong>Cardiac studies<\/strong> \u2014 heart failure, ischemia-reperfusion, cardiomyopathy, and cardiotoxicity rescue studies (Szeto, AAPS J 2014)<\/li>\n<li><strong>Renal studies<\/strong> \u2014 acute kidney injury, ischemia-reperfusion, and chronic kidney disease studies (Birk et al., J Am Soc Nephrol 2013)<\/li>\n<li><strong>Aging studies<\/strong> \u2014 disfun\u00e7\u00e3o mitocondrial relacionada \u00e0 idade, envelhecimento do m\u00fasculo esquel\u00e9tico (sarcopenia) e marcadores gerais de envelhecimento celular<\/li>\n<li><strong>Neuroprotection studies<\/strong> \u2014 ischemic-stroke and neurodegeneration studies where mitochondrial dysfunction is a driver<\/li>\n<li><strong>Sarcopenia studies<\/strong> \u2014 skeletal-muscle mitochondrial function and age-related muscle loss studies<\/li>\n<li><strong>Comparative mitochondrial-agent studies<\/strong> \u2014 lado a lado com <a href=\"https:\/\/medsbase.com\/pt-br\/nad\/\">NAD+<\/a> (coenzima mitocondrial) e MitoQ (outro antioxidante direcionado \u00e0s mitoc\u00f4ndrias) para isolar o mecanismo<\/li>\n<\/ul>\n<p>For broader context on longevity and mitochondrial-compounds see the <a href=\"https:\/\/medsbase.com\/pt-br\/peptides\/\">cat\u00e1logo de pept\u00eddeos<\/a>. <\/p>\n<h2>Concentra\u00e7\u00f5es e Dosagens Dispon\u00edveis<\/h2>\n<p>A MedsBase possui SS-31 (Elamipretide) nos seguintes tamanhos de frascos liofilizados:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosagem do Frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de Uso T\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos de Embalagem<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, low-dose rodent work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, extended rodent studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Large-scale studies, clinical-trial-matched doses (40 mg\/day), lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The 50\u00a0mg vial size matches the clinical-trial 40 mg\/day dose used in Stealth BioTherapeutics&#8217;s human studies. Preclinical rodent studies typically uses smaller vials matched to 1\u20135 mg\/kg body weight. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>Compara\u00e7\u00e3o \u2014 SS-31 vs Outros Compostos Mitocondriais \/ de Longevidade<\/h2>\n<p>SS-31 is part of a small but growing class of mitochondria-targeted studies agents. Key comparisons:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">SS-31 (Elamipretide)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD+<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Alvo prim\u00e1rio<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cardiolipina (lip\u00eddio da membrana mitocondrial interna)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sirtu\u00ednas, enzimas PARP, ETC<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Express\u00e3o g\u00eanica, sinaliza\u00e7\u00e3o pineal<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Evid\u00eancia mecanicista<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Forte (v\u00e1rios laborat\u00f3rios, ensaios cl\u00ednicos)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Muito forte (bioqu\u00edmica bem caracterizada)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Grupo restrito (Khavinson)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Status cl\u00ednico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">FDA orphan-drug, Fase 3 (s\u00edndrome de Barth)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">N\u00e3o aprovado (uso em terapia intravenosa)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">N\u00e3o aprovado<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Isquemia card\u00edaca, renal, sarcopenia<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Longevidade, energia, reparo de DNA<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tel\u00f4mero, circadiano<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201340 mg di\u00e1rios (cl\u00ednico); 1\u20135 mg\/kg (pr\u00e9-cl\u00ednico)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\u2013100 mg di\u00e1rios<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201310 mg SC diariamente<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>SS-31 is distinct because it is the only peptide targeting a mitochondrial lipid directly. Users often study it alongside <a href=\"https:\/\/medsbase.com\/pt-br\/nad\/\">NAD+<\/a> (para cobertura complementar da via das sirtu\u00ednas) e <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> in multi-pathway longevity protocols. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original, est\u00e1veis por at\u00e9 36 meses. Evite ciclos de congelamento-descongelamento no p\u00f3. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> injete \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco de pept\u00eddeo conforme o gr\u00e1fico acima. Agite suavemente \u2014 n\u00e3o <strong>n\u00e3o<\/strong> sacuda \u2014 e aguarde 5\u201310 minutos para dissolu\u00e7\u00e3o completa. A solu\u00e7\u00e3o deve estar l\u00edmpida e incolor. <strong>Ap\u00f3s a reconstitui\u00e7\u00e3o:<\/strong> armazene refrigerado a 2\u20138 \u00b0C e use dentro de 30 dias. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is SS-31 used for in studies?<\/h3>\n<p>SS-31 (Elamipretide) is used in studies investigating mitochondrial disease (including Barth syndrome), cardiac ischemia-reperfusion, heart failure, acute kidney injury, chronic kidney disease, age-related mitochondrial dysfunction, sarcopenia, and neuroprotection. It has FDA orphan-drug designation but is <strong>n\u00e3o<\/strong> yet FDA-approved for therapeutic use. Sold here strictly for clinical studies use only. <\/p>\n<h3>How is SS-31 different from other peptides?<\/h3>\n<p>O SS-31 \u00e9 \u00fanico porque seu alvo \u00e9 <strong>cardiolipina<\/strong> \u2014 a phospholipid on the inner mitochondrial membrane \u2014 not a cell-surface receptor. It is cell-permeable and reaches the mitochondrial matrix to stabilize cristae architecture and preserve electron-transport-chain function. Virtually every other peptide binds receptors on the cell surface. <\/p>\n<h3>What is the typical SS-31 dose?<\/h3>\n<p>Stealth BioTherapeutics&#8217; clinical trials have used 40\u00a0mg SC daily. Preclinical rodent studies typically uses 1\u20135\u00a0mg\/kg body weight daily. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5.0\u00a0mg\/mL \u2014 100 ticks on a U-100 syringe delivers 5\u00a0mg. <\/p>\n<h3>O SS-31 \u00e9 aprovado pela FDA?<\/h3>\n<p>O SS-31 (Elamipretide) tem a designa\u00e7\u00e3o de medicamento \u00f3rf\u00e3o pela FDA para miopatia mitocondrial prim\u00e1ria e est\u00e1 em desenvolvimento cl\u00ednico em fase avan\u00e7ada pela Stealth BioTherapeutics. Ele est\u00e1 <strong>n\u00e3o<\/strong> yet fully FDA-approved. All SS-31 sold by specialist suppliers is for clinical investigation, not the clinical-trial therapeutic product. <\/p>\n<h3>O que significa a abrevia\u00e7\u00e3o \u201cSS-31\u201d?<\/h3>\n<p>SS-31 significa <strong>composto Szeto-Schiller 31<\/strong>, after the Cornell users Hazel Szeto and Peter Schiller who developed the SS-series of mitochondria-targeted peptides in the 1990s and 2000s. The &#8220;31&#8221; is simply the compound number in their synthesis series. The compound was later licensed to Stealth BioTherapeutics and renamed Elamipretide (and Bendavia) for clinical development. <\/p>\n<h3>Como o SS-31 deve ser armazenado?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138 \u00b0C na embalagem original, est\u00e1veis por at\u00e9 36 meses. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138 \u00b0C, usar em at\u00e9 30 dias. N\u00e3o congelar a solu\u00e7\u00e3o reconstitu\u00edda. <\/p>\n<h3>Como devo reconstituir o SS-31?<\/h3>\n<p>Siga o gr\u00e1fico de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica na parede lateral do frasco, agite suavemente e aguarde 5 a 10 minutos para a dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> agite. <\/p>\n<h3>Can SS-31 be stacked with NAD+ in studies?<\/h3>\n<p>Yes \u2014 this is a common multi-pathway mitochondrial studies combination. SS-31 stabilizes cristae architecture and cardiolipin-dependent ETC function; <a href=\"https:\/\/medsbase.com\/pt-br\/nad\/\">NAD+<\/a> fornece substrato coenzim\u00e1tico para a cadeia transportadora de el\u00e9trons e sinaliza\u00e7\u00e3o sirtu\u00edna\/PARP downstream. Os mecanismos s\u00e3o complementares e n\u00e3o sobrepostos. <\/p>\n<h3>Quais dosagens a MedsBase oferece?<\/h3>\n<p>MedsBase carries SS-31 (Elamipretide) in 5\u00a0mg, 10\u00a0mg, and 50\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis on request. <\/p>\n<h3>Does SS-31 cause side reported effects?<\/h3>\n<p>Published preclinical and clinical-trial has reported a favorable safety profile. Most commonly reported effects in the clinical-trial literature are injection-site reactions. Because SS-31 has been studied in multiple human trials (Phase 2 and Phase 3), its safety profile is better-characterised than most peptides. <\/p>\n<h3>O SS-31 \u00e9 o mesmo que Bendavia ou Elamipretida?<\/h3>\n<p>Sim. O mesmo composto possui tr\u00eas nomes: <strong>SS-31<\/strong> (original Szeto-Schiller studies designation), <strong>Bendavia<\/strong> (nome de desenvolvimento inicial da Stealth BioTherapeutics), e <strong>Elamipretide<\/strong> (international nonproprietary name \/ INN). Studies literature uses SS-31 predominantly; clinical-trial literature uses Elamipretide or Bendavia. <\/p>\n<h3>Qual \u00e9 a meia-vida do SS-31?<\/h3>\n<p>O SS-31 (elamipretida) tem uma meia-vida plasm\u00e1tica curta de aproximadamente 30\u201360 minutos ap\u00f3s administra\u00e7\u00e3o subcut\u00e2nea, mas demonstra acumula\u00e7\u00e3o mitocondrial prolongada devido \u00e0 sua afinidade pela cardiolipina na membrana mitocondrial interna. A meia-vida tecidual em \u00f3rg\u00e3os ricos em mitoc\u00f4ndrias, como m\u00fasculo card\u00edaco e esquel\u00e9tico, \u00e9 estimada em v\u00e1rias horas al\u00e9m da depura\u00e7\u00e3o plasm\u00e1tica. <\/p>\n<h3>Como o SS-31 atinge especificamente as mitoc\u00f4ndrias?<\/h3>\n<p>O SS-31 \u00e9 um pept\u00eddeo Szeto-Schiller com uma estrutura arom\u00e1tica-cati\u00f4nica alternada (D-Arg-dimetil-Tyr-Lys-Phe-NH\u2082). Essa sequ\u00eancia impulsiona a acumula\u00e7\u00e3o na membrana mitocondrial interna em aproximadamente 1.000 vezes acima dos n\u00edveis citoplasm\u00e1ticos, mediada por atra\u00e7\u00e3o eletrost\u00e1tica ao fosfolip\u00eddeo cardiolipina carregado negativamente. A liga\u00e7\u00e3o \u00e0 cardiolipina estabiliza os complexos da cadeia de transporte de el\u00e9trons e reduz a produ\u00e7\u00e3o de esp\u00e9cies reativas de oxig\u00eanio (ROS). <\/p>\n<h3>Posso encomendar SS-31 para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia SS-31 para todo o mundo a partir de nossa rede dedicada de envio de pept\u00eddeos. Pedidos exclusivos de pept\u00eddeos qualificam-se para nosso servi\u00e7o de envio de pept\u00eddeos independente. Os pedidos s\u00e3o enviados em embalagens com controle de temperatura e rastreamento completo. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/pt-br\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/pt-br\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/pt-br\/ipamorelin\/\"><strong>Ipamorelina<\/strong><\/a> \u2014 Agonista seletivo de grelina \u2014 pulso de GH limpo sem cortisol\/prolactina<\/li>\n<li><a href=\"\/pt-br\/cjc-1295-with-dac\/\"><strong>CJC-1295 com DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH com meia-vida prolongada<\/li>\n<li><a href=\"\/pt-br\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Leia nosso guia completo baseado em evid\u00eancias: <a href=\"https:\/\/medsbase.com\/pt-br\/ss-31-elamipretide-mitochondrial-guide\/\"><strong>SS-31 (Elamipretide) \u2014 cardiolipin targeting, mitochondrial studies &amp; clinical trials<\/strong><\/a>. Covers Szeto-Schiller mechanism studies, Stealth BioTherapeutics clinical development, cardiac\/renal\/neurological applications, and realistic context.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Melhora a energia celular<br \/>\n\u2705 Suporta a fun\u00e7\u00e3o mitocondrial<br \/>\n\u2705 Reduz o estresse oxidativo<br \/>\n\u2705 Melhora a resist\u00eancia dos tecidos<br \/>\n\u2705 Promove efici\u00eancia metab\u00f3lica<\/p>\n<p><strong>SS-31<\/strong> cont\u00e9m composto de pept\u00eddeo sint\u00e9tico.<\/p>","protected":false},"featured_media":70982,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5476,5475],"class_list":["post-69029","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-elamipretide","product_tag-ss-31","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product\/69029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/comments?post=69029"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media\/70982"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media?parent=69029"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_brand?post=69029"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_cat?post=69029"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_tag?post=69029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}